MoneyInvestor's Business Daily
AstraZeneca Stock Trips On Unexpected Failure In Breast Cancer
AstraZeneca stock toppled in late trades Friday after the company's experimental breast cancer treatment failed to pass muster. The post AstraZeneca Stock Trips On Unexpected Failure In Breast Cancer appeared first on Investor's Business Daily.
Join the argument
House rules βComments load as you scroll.